Blog
Month: October 2019

Chain of Identity and Chain of Custody in personalized therapies — core differences from traditional pharma

Blog

In pharmaceutical manufacturing, Chain of Identity and Chain of Custody may not be new — but in advanced therapy manufacturing,...

Q&A with Dr. Mike Pellini: the need for advanced software to scale cell and gene therapies

Blog

Mike Pellini, M.D., is a member of Vineti’s Board of Directors, a Managing Partner at Section 32, and the former...

Supply chain vs. value chain: need-to-know essentials

Blog

In a recent blog post about Quality Risk Management, we talked about the importance of considering the entire “value chain” when...

Design for personalized therapies: reframing “delight” as the goal

Blog

Sometimes, in the world of UX and product design, “delight” means getting out of the way. Read about general approaches...